Lumpy skin disease epidemiological report IV: data collection and analysis

Abstract In 2019, no lumpy skin disease (LSD) outbreaks were reported in South‐Eastern Europe, the mass vaccination regional campaign with homologous LSD vaccine continued for the fourth year with over 1.8 million bovines vaccinated in the region, preventing further outbreaks since 2016. LSD outbreaks were reported in Turkey, including western Turkey, in Russia and in eastern Asia affecting China, Bangladesh and India for the first time. The use of homologous vaccine should be considered in the countries still affected in order to eliminate the virus. Besides passive surveillance, which is implemented in all the countries, active surveillance for early detection based on clinical examination could be conducted ideally during April–October every 5 weeks in at‐risk areas, based on possible re‐emergence or re‐introduction from affected neighbouring countries. Active surveillance for proving disease freedom could be based on serological testing (enzyme‐linked immunosorbent assay (ELISA)) targeting 3.5% seroprevalence and conducted on a random sample of cattle herds on non‐vaccinated animals. LSD re‐emerged in Israel in 2019, after vaccination became voluntary. This shows that, if the virus is still circulating in the region, the reduced protection might result in re‐emergence of LSD. In case of re‐emergence, a contingency plan and vaccine stockpiling would be needed, in order to react quickly. From a study performed in Israel to test side effects of live‐attenuated homologous LSD vaccine, milk production can be reduced during 7 days after vaccination (around 6–8 kg per cow), without a significant loss in the 30 days after vaccination. Research needs should be focused on the probability of transmission from insect to bovine, the virus inactivation rate in insects, the collection of baseline entomological data, the capacity of vector species in LSDV transmission linked to studies on their abundance and the control of Stomoxys calcitrans being the most important vector in LSD transmission.

[1]  Y. Yıldırım,et al.  Lumpy Skin Disease , 2019, Etlik Veteriner Mikrobiyoloji Dergisi.

[2]  K. De Clercq,et al.  An Immunoperoxidase Monolayer Assay (IPMA) for the detection of lumpy skin disease antibodies , 2019, Journal of virological methods.

[3]  N. De Regge,et al.  Experimental evidence of mechanical lumpy skin disease virus transmission by Stomoxys calcitrans biting flies and Haematopota spp. horseflies , 2019, Scientific Reports.

[4]  Antonio J. González,et al.  High resolution and sensitivity gamma camera with active septa. A first Monte Carlo study , 2019, Scientific Reports.

[5]  M. Beer,et al.  Experimental lumpy skin disease virus infection of cattle: comparison of a field strain and a vaccine strain , 2019, Archives of Virology.

[6]  A. Williamson,et al.  The complete genome sequence of the lumpy skin disease virus vaccine Herbivac LS reveals a mutation in the superoxide dismutase gene homolog , 2019, Archives of Virology.

[7]  Kononov Aleksandr,et al.  A real-time PCR screening assay for the universal detection of lumpy skin disease virus DNA , 2019, BMC Research Notes.

[8]  B. Hoffmann,et al.  Molecular characterization of Capripox viruses obtained from field outbreaks in Nigeria between 2000 and 2016. , 2019, Transboundary and emerging diseases.

[9]  Y. Stram,et al.  Importance of the lumpy skin disease virus (LSDV) LSDV126 gene in differential diagnosis and epidemiology and its possible involvement in attenuation , 2019, Archives of Virology.

[10]  M. Petrović,et al.  Epizootic features and control measures for lumpy skin disease in south-east Serbia in 2016. , 2019, Transboundary and emerging diseases.

[11]  S. Gubbins Using the basic reproduction number to assess the risk of transmission of lumpy skin disease virus by biting insects , 2019, bioRxiv.

[12]  V. Mischenko,et al.  Detection of vaccine-like strains of lumpy skin disease virus in outbreaks in Russia in 2017 , 2019, Archives of Virology.

[13]  B. Hoffmann,et al.  Humoral immune response to repeated lumpy skin disease virus vaccination and performance of serological tests , 2019, BMC Veterinary Research.

[14]  C. Saegerman,et al.  Risk of introduction of Lumpy Skin Disease into France through imports of cattle , 2019, Transboundary and emerging diseases.

[15]  A. Sprygin,et al.  Complete Genome Sequence of the Lumpy Skin Disease Virus Recovered from the First Outbreak in the Northern Caucasus Region of Russia in 2015 , 2019, Microbiology Resource Announcements.

[16]  A. Perez,et al.  Mapping changes in the spatiotemporal distribution of lumpy skin disease virus , 2019, bioRxiv.

[17]  C. Saegerman,et al.  A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France , 2019, PloS one.

[18]  A. Allepuz,et al.  Spatial analysis of lumpy skin disease in Eurasia—Predicting areas at risk for further spread within the region , 2018, Transboundary and emerging diseases.

[19]  A. Kononov,et al.  Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field , 2018, PloS one.

[20]  P. Calistri,et al.  Lumpy skin disease: scientific and technical assistance on control and surveillance activities , 2018, EFSA journal. European Food Safety Authority.

[21]  P. Gale,et al.  A generic framework for spatial quantitative risk assessments of infectious diseases: Lumpy skin disease case study , 2018, Transboundary and emerging diseases.

[22]  S. Abutarbush,et al.  Serological and clinical evaluation of the Yugoslavian RM65 sheep pox strain vaccine use in cattle against lumpy skin disease , 2018, Transboundary and emerging diseases.

[23]  N. Krešić,et al.  Complete Genome Sequence of a Lumpy Skin Disease Virus Strain Isolated from the Skin of a Vaccinated Animal , 2018, Genome Announcements.

[24]  N. Krešić,et al.  Detection of lumpy skin disease virus in skin lesions, blood, nasal swabs and milk following preventive vaccination. , 2018, Transboundary and emerging diseases.

[25]  Z. Polizopoulou,et al.  Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease , 2018, Transboundary and emerging diseases.

[26]  M. Şevik,et al.  Epidemiological and Molecular Studies on Lumpy Skin Disease Outbreaks in Turkey during 2014–2015 , 2017, Transboundary and emerging diseases.

[27]  I. Toplak,et al.  Complete Genome Sequence of Lumpy Skin Disease Virus Isolate SERBIA/Bujanovac/2016, Detected during an Outbreak in the Balkan Area , 2017, Genome Announcements.

[28]  K. De Clercq,et al.  Complete Genome Sequence of the Lumpy Skin Disease Virus Isolated from the First Reported Case in Greece in 2015 , 2017, Genome Announcements.

[29]  S. Gubbins,et al.  Lumpy skin disease: I. Data collection and analysis , 2017, EFSA journal. European Food Safety Authority.

[30]  N. Galon,et al.  Lumpy skin disease: current situation in Europe and neighbouring regions and necessary control measures to halt the spread in south-east Europe , 2016 .

[31]  Y. Stram,et al.  Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study. , 2015, Vaccine.

[32]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.

[33]  C. Embury-Hyatt,et al.  Quantification of lumpy skin disease virus following experimental infection in cattle. , 2008, Transboundary and emerging diseases.

[34]  J. Coetzer,et al.  The detection of lumpy skin disease virus in samples of experimentally infected cattle using different diagnostic techniques. , 2005, The Onderstepoort journal of veterinary research.

[35]  R. Kitching,et al.  Attempted mechanical transmission of lumpy skin disease virus by biting insects , 2003, Medical and veterinary entomology.

[36]  R. Kitching,et al.  Mechanical transmission of lumpy skin disease virus by Aedes aegypti (Diptera: Culicidae) , 2001, Epidemiology and Infection.

[37]  R. Kitching,et al.  An investigation of possible routes of transmission of lumpy skin disease virus (Neethling) , 1995, Epidemiology and Infection.

[38]  A. Williamson,et al.  Removal of bovine viral diarrhea virus (BVDV) from lumpy skin disease virus (LSDV) vaccine stocks by passage on chorioallantoic membranes of fertilized hens' eggs. , 2019, Journal of virological methods.

[39]  V. Rutten,et al.  Transboundary and Emerging Diseases , 2013 .

[40]  R. Watson,et al.  On the spread of a disease with gamma distributed latent and infectious periods , 1980 .